KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Other Operating Expenses (2016 - 2025)

Zimmer Biomet Holdings has reported Other Operating Expenses over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Other Operating Expenses at $1.1 billion for Q4 2025, up 41.01% from a year ago — trailing twelve months through Dec 2025 was $3.4 billion (up 12.95% YoY), and the annual figure for FY2025 was $3.4 billion, up 12.96%.
  • Other Operating Expenses for Q4 2025 was $1.1 billion at Zimmer Biomet Holdings, up from $722.8 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for ZBH hit a ceiling of $1.1 billion in Q4 2025 and a floor of $604.7 million in Q1 2021.
  • Median Other Operating Expenses over the past 5 years was $723.1 million (2024), compared with a mean of $751.3 million.
  • Peak annual rise in Other Operating Expenses hit 156.82% in 2021, while the deepest fall reached 53.77% in 2021.
  • Zimmer Biomet Holdings' Other Operating Expenses stood at $742.2 million in 2021, then soared by 37.2% to $1.0 billion in 2022, then fell by 26.32% to $750.3 million in 2023, then grew by 3.81% to $778.9 million in 2024, then soared by 41.01% to $1.1 billion in 2025.
  • The last three reported values for Other Operating Expenses were $1.1 billion (Q4 2025), $722.8 million (Q3 2025), and $849.2 million (Q2 2025) per Business Quant data.